United States Antimony Corporation
(NYSE MKT:UAMY)

United States Antimony Corporation produces and sells antimony, silver, gold, and zeolite products in the United States and Canada. The company's Antimony division offers antimony oxide that is primarily used in conjunction with a halogen to form a synergistic flame retardant system for plastics, ru...

Website: http://www.usantimony.com

Founded: 1968

Full Time Employees: 97

Sector: Basic Materials

Industry: Other Industrial Metals & Mining

Materials Antimony

Share this website to your friends

• Market Cap:

• Exchange:

• Shs Outstanding:

• Employees:

• Beta:

• Return on Equity (ROE) ttm:

• Return on Assets (ROA) ttm:

• EPS ttm:

• Book value per Share:

• Cash per Share:

• Current ast per Share:

• P/E ttm:

• P/E forward:

• P/E ttm high:

• P/E ttm low:

• P/S ttm:

• P/B ttm:

• P/FCF ttm:

• PEG ratio:

• Cash Ratio ttm:

• Quick Ratio ttm:

• Current Ratio ttm:

• Gross Mgn ttm:

• EBITDA Mgn ttm:

• Operating Mgn ttm:

• Net Income Mgn ttm:

• Trailing Div yield:

• Forward Div yield:

• Payout Ratio ttm:

• Ex-Dividend date:

• Target Price High:

• Target Price Low:

• Target Price Mean:

• Number of Analysts:

• Debt Ratio ttm:

• Debt to Equity ttm:

• Total Net Debt:

At a glance:

Bull Thesis:

Bear Thesis:

Main Competitors:

Moat:

Income Statements:

Quarterly

Annual

Unit: USD	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31	2019-12-31	2019-09-30	2019-06-30	2019-03-31	2018-12-31	2018-09-30	2018-06-30	2018-03-31	2017-12-31	2017-09-30	2017-06-30	2017-03-31	2016-12-31	2016-09-30	2016-06-30	2016-03-31	2015-12-31	2015-09-30	2015-06-30	2015-03-31	2014-12-31	2014-09-30	2014-06-30	2014-03-31	2013-12-31	2013-09-30	2013-06-30	2013-03-31	2012-12-31	2012-09-30	2012-06-30	2012-03-31	2011-12-31	2011-09-30	2011-06-30	2011-03-31	2010-12-31	2010-09-30	2010-06-30	2010-03-31	2009-12-31	2009-09-30	2009-06-30

revenues	6,784,069	13,030,629	8,701,951	10,525,123	7,000,005	6,871,772	2,421,020	2,813,780	2,831,390									2,166,944	2,051,713	2,275,562	1,253,287	900,117	1,007,231	1,585,191	1,742,991	1,751,423	1,787,934	2,272,283	2,456,365	2,253,402	2,091,725	2,256,347	2,432,929	2,402,453	2,369,714	2,838,480	2,619,330	2,723,507	2,846,699	3,014,394	3,322,203	3,255,876	3,505,452	2,270,143	2,947,381	2,598,278	2,951,457	2,270,143	2,952,314	2,541,021	2,558,356	2,954,677	2,966,775	2,835,724	2,655,123	3,498,301	3,053,554	3,856,051	3,332,008	3,050,002	2,838,039	4,641,300	1,899,469	1,529,475	1,003,080	709,562	801,601	581,208
cost of revenues	5,674,602	10,379,834	6,688,509	7,687,578	4,628,275	5,562,167	1,995,252	1,905,139	2,008,486									1,838,103	1,950,504	2,079,164	1,041,130	344,444	1,442,322	1,601,252	1,641,814	2,054,609	2,058,751	2,445,478	2,525,418	2,160,990	2,268,854	2,114,999	2,488,017	2,687,558	2,315,646	2,535,587	2,529,786	2,541,821	2,888,660	2,824,779	3,111,375	23,153,979	-3,273,324	2,409,000	3,051,434	19,747,104	-3,221,717	2,409,000	3,004,854	19,489,159	-2,441,862	2,956,589	3,028,909	19,667,505	-2,517,497	3,209,381	2,890,144	3,530,813	2,505,682	2,709,491	2,491,519
gross profit	1,109,467	2,650,795	2,013,442	2,837,545	2,371,730	1,309,605	425,768	908,641	822,904	-2,044,189	-1,061,072	295,896	-535,419	-288,922	430,918	722,410	1,139,388	328,841	101,209	196,398	212,157	555,673	-435,091	-16,061	101,177	-303,186	-270,817	-173,195	-69,053	92,412	-177,129	141,348	-55,088	-285,105	54,068	302,893	89,544	181,686	-41,961	189,615	210,828	-632,871	232,128	-138,857	-104,053	122,316	-270,260		-52,540	-93,418	116,494	-1,912	-62,134	487,625	137,626	288,920	163,410	325,238	826,326	340,511	346,520
yoy	-53.22%	102.41%	372.90%	212.28%	188.21%	-164.06%	-140.13%	207.08%	-253.69%	607.52%	-346.24%	-59.04%	-146.99%	-187.86%	325.77%	267.83%	437.05%	-40.82%	-123.26%	-1322.83%	109.69%	-283.28%	60.66%	-90.73%	-246.52%	-428.08%	52.89%	-222.53%	25.35%	-132.41%	-427.60%	-53.33%	-161.52%	-256.92%	-228.85%	59.74%	-57.53%	-128.71%	-118.08%	-236.55%	-302.62%	-617.41%	-185.89%		98.05%	-230.93%	-331.99%		-15.44%	-119.16%	-15.35%	-100.66%	-138.02%	49.93%	-83.34%	-15.15%	-52.84%
qoq	-58.15%	31.65%	-29.04%	19.64%	81.10%	207.59%	-53.14%	10.42%	-140.26%	92.65%	-458.60%	-155.26%	85.32%	-167.05%	-40.35%	-36.60%	246.49%	224.91%	-48.47%	-7.43%	-61.82%	-227.71%	2608.99%	-115.87%	-133.37%	11.95%	56.37%	150.81%	-174.72%	-152.17%	-225.31%	-356.59%	-80.68%	-627.31%	-82.15%	238.26%	-50.71%	-532.99%	-122.13%	-10.06%	-133.31%	-372.64%	-267.17%	33.45%	-185.07%	-145.26%			-43.76%	-180.19%	-6192.78%	-96.92%	-112.74%	254.31%	-52.37%	76.81%	-49.76%	-60.64%	142.67%	-1.73%
gross margin %	Infinity%	Infinity%	Infinity%	Infinity%	Infinity%	Infinity%	Infinity%	Infinity%	Infinity%	-116.35%	-45.86%	11.82%	-24.22%	-20.35%	17.49%	20.13%	31.82%	Infinity%	Infinity%	Infinity%	Infinity%	Infinity%	-Infinity%	-Infinity%	Infinity%	-Infinity%	-Infinity%	-Infinity%	-Infinity%	Infinity%	-Infinity%	Infinity%	-Infinity%	-Infinity%	Infinity%	Infinity%	Infinity%	Infinity%	-Infinity%	Infinity%	Infinity%	-Infinity%	Infinity%	-Infinity%	-Infinity%	Infinity%	-Infinity%	NaN%	-Infinity%	-Infinity%	Infinity%	-Infinity%	-Infinity%	Infinity%	Infinity%	Infinity%	Infinity%	Infinity%	Infinity%	Infinity%	Infinity%	NaN%	NaN%	NaN%	NaN%	NaN%	NaN%	NaN%
operating expenses:
general and administrative	1,331,969	848,578	882,909	842,951	550,595	531,276	588,816	477,366	455,394	821,233	301,077	364,365	155,594	168,432	108,538	220,591	160,681	104,653	112,744	290,111	170,050	182,191	108,643	116,560	199,971	167,385	139,456	153,909	205,174	306,766	151,825	186,411	150,831	-229,239	228,185	236,482	200,592	-168,768	309,832	270,514	163,877	-165,195	334,617	244,726	-270,736	-48,804	220,150	244,726	207,497	68,324	206,467	237,002	224,518	155,292	239,093	228,411	225,921	379,577	28,582	89,967	80,349	295,396	18,247	22,832	16,329	17,628	20,658	21,546
salaries and benefits	5,879,794	4,275,257	4,940,319	1,364,506	1,000,555	1,393,619	429,438	285,359	241,605	137,101	228,967	145,412	127,692	258,248	76,811	72,912	73,135	72,369	72,200	77,278	76,659	79,036	82,308	111,178	94,969	94,550	91,178	100,362	232,668	94,192	93,723	96,427	91,446				97,487				109,589
professional fees	1,281,131	914,205	522,531	536,869	382,036	404,225	165,839	221,529	177,157	138,389	166,808	253,205	84,806				122,077	51,939	28,227	61,199	123,137	85,451	43,557	32,652	84,958	81,887	40,010	22,452	100,742	31,260	211,583	18,563	102,404	25,466	53,045	34,582	103,338	55,609	29,004	79,815	143,650	92,096	45,947	27,084	-111,789	37,428	51,595	27,084	91,238	37,009	58,827	27,068	101,985	71,369	54,722	34,337	98,306	44,300	34,764	30,888	94,952
gain on sale or disposal of property, plant and equipment	-1,900
other operating expenses	135,668	472,371	1,062,903	73,212	81,052	234,049	102,970	137,991		363,662	66,637	43,003	108,345			14,045	3,915				184,037	660,111		25	24,225	1,717		10,500	76,130																																	228,598	562,793	104,952	246,647
total operating expenses	8,626,662	6,570,477	6,930,624	2,817,538	2,013,738	2,573,024	1,270,811	1,122,245	891,650	1,678,306	763,489	805,985	476,437	562,270	370,432	355,475	359,808	303,220	213,171	428,588	553,883	2,292,892	553,010	260,415	404,123	1,756,275	270,644	287,223	614,714	-148,706	-1,042,869	301,401	344,681	167,389	281,230	271,064	401,417	359,841	306,023	297,741	393,125	328,552	337,176	271,810	549,693	376,707	271,745	271,810	293,285	441,333	265,294	264,070	326,503	511,144	293,815	262,748	324,227	423,877	63,346	216,888	242,954
income from operations	-7,517,195	-3,919,682	-4,917,182	20,007	357,992	-1,263,419	-845,043	-213,604	-68,746	-3,722,495	-1,824,561	-510,089	-1,011,856	-851,192	60,486	366,935	779,580	25,621	-111,962	-232,190	-341,726	-1,737,219	-988,101	-276,476	-302,946	-2,059,461	-541,461	-460,418	-683,767	241,118	865,740	-160,053	-399,769	-452,494	-227,162	31,829	-311,873	-178,155	-347,984	-108,126	-182,297	-961,423	-105,048	-410,667		-254,391	-542,005	-410,667	-345,825	-534,751	-148,800	-265,982	-388,637	-23,519	-156,189	26,172	-160,817	-98,639	762,980	123,623	103,566	140,823	126,664	231,941	-75,859
yoy	-2199.82%	210.24%	481.89%	-109.37%	-620.75%	-66.06%	-53.69%	-58.12%	-93.21%	337.33%	-3116.50%	-239.01%	-229.80%	-3422.24%	-154.02%	-258.03%	-328.13%	-101.47%	-88.67%	-16.02%	12.80%	-15.65%	82.49%	-39.95%	-55.69%	-954.13%	-162.54%	187.67%	71.04%	-153.29%	-481.11%	-602.85%	28.18%	153.99%	-34.72%	-129.44%	71.08%	-81.47%	231.26%	-73.67%		277.93%	-80.62%	0.00%		-52.43%	264.25%	54.40%	-11.02%	2173.70%	-4.73%	-1116.28%	141.66%	-76.16%	-120.47%	-78.83%	-255.28%	-170.04%	502.37%	-46.70%	-236.52%
qoq	91.78%	-20.29%	-24677.31%	-94.41%	-128.34%	49.51%	295.61%	210.71%	-98.15%	104.02%	257.69%	-49.59%	18.88%	-1507.25%	-83.52%	-52.93%	2942.74%	-122.88%	-51.78%	-32.05%	-80.33%	75.81%	257.39%	-8.74%	-85.29%	280.35%	17.60%	-32.66%	-383.58%	-72.15%	-640.91%	-59.96%	-11.65%	99.19%	-813.70%	-110.21%	75.06%	-48.80%	221.83%	-40.69%	-81.04%	815.22%	-74.42%			-53.06%	31.98%	18.75%	-35.33%	259.38%	-44.06%	-31.56%	1552.44%	-84.94%	-696.78%	-116.27%	63.04%	-112.93%	517.18%	19.37%	-26.46%	11.18%	-45.39%	-405.75%
operating margin %	-Infinity%	-Infinity%	-Infinity%	Infinity%	Infinity%	-Infinity%	-Infinity%	-Infinity%	-Infinity%	-211.87%	-78.87%	-20.37%	-45.77%	-59.94%	2.45%	10.23%	21.77%	Infinity%	-Infinity%	-Infinity%	-Infinity%	-Infinity%	-Infinity%	-Infinity%	-Infinity%	-Infinity%	-Infinity%	-Infinity%	-Infinity%	Infinity%	Infinity%	-Infinity%	-Infinity%	-Infinity%	-Infinity%	Infinity%	-Infinity%	-Infinity%	-Infinity%	-Infinity%	-Infinity%	-Infinity%	-Infinity%	-Infinity%	NaN%	-Infinity%	-Infinity%	-Infinity%	-Infinity%	-Infinity%	-Infinity%	-Infinity%	-Infinity%	-Infinity%	-Infinity%	Infinity%	-Infinity%	-Infinity%	Infinity%	Infinity%	Infinity%	Infinity%	Infinity%	Infinity%	-Infinity%	NaN%	NaN%	NaN%
other income, net:
interest and investment income	328,288	337,827	150,563	154,770	192,156	208,014	157,757	151,921	150,851	151,953	176,656	167,781	122,372	11,148	15,064	30,052
unrealized loss on investment in equity securities	-4,061,430
other miscellaneous expense	-28,027	-2,873.5	-21,948		-14,467
total other income	-3,761,169	3,632,777	136,482	161,548	188,532	185,715	161,946	157,900	154,847	162,185	180,033	173,624	204,872	105,653	-10,084	-5,712	6,672	11,489	12,730	569,331	6,238	26,820	-5,139	2,193	-5,936	148,661	-27,131	-25,621	-23,693	-370,447	401,707	37,268	-74,671	-11,077	-35,403	-48,784	-79,430	-114,064	-37,583	-36,544	-6,343			-13,605	-5,612			-13,605	-12,345			-56,775	-20,188	-6,010	-18,936
income before income taxes and equity in losses of joint venture	-11,278,364
income tax expense																																																										6,106.5			24,426
income before equity in losses of joint venture	-11,278,364
equity in losses of joint venture	-16,126
net income	-11,294,490	-286,905	-4,780,700	181,555	546,524	-882,919	-727,509	202,792	-322,768	-3,560,310	-1,644,528	-336,465	-806,984	-761,612	50,402	361,223	786,252	37,110	-99,232	337,141	-335,488	-1,710,399	-993,240	-274,283	-308,882			-486,039	-707,460			-122,785	-474,440	-463,571	-262,565	-16,955	-391,303	-166,867	-797,057	-156,670	-188,640	-944,907	-135,890	-424,272	440,028	-253,684	-559,329	-424,272	-358,170	-555,582	-158,813	-552,208	-408,825	-270,947	-175,125	3,770	-116,233	-202,946	708,073	86,428	45,363	598,932	85,815	204,583	-84,117	31,060	-49,718	-37,141
yoy	-2166.60%	-67.50%	557.13%	-10.47%	-269.32%	-75.20%	-55.76%	-160.27%	-60.00%	367.47%	-3362.82%	-193.15%	-202.64%	-2152.31%	-150.79%	7.14%	-334.36%	-102.17%	-90.01%	-222.92%	8.61%			-43.57%	-56.34%			295.85%	49.11%			624.18%	21.25%	177.81%	-67.06%	-89.18%	107.43%	-82.34%	486.55%	-63.07%	-142.87%	272.47%	-75.70%	0.00%	-222.85%	-54.34%	252.19%	-23.17%	-12.39%	105.05%	-9.31%	-14747.43%	251.73%	33.51%	-124.73%	-95.64%	-356.23%	-133.88%	725.12%	-57.75%	-153.93%	1828.31%	-272.60%	-650.83%
qoq	3836.67%	-94.00%	-2733.20%	-66.78%	-161.90%	21.36%	-458.75%	-162.83%	-90.93%	116.49%	388.77%	-58.31%	5.96%	-1611.07%	-86.05%	-54.06%	2018.71%	-137.40%	-129.43%	-200.49%	-80.39%	72.20%	262.12%	-11.20%				-31.30%				-74.12%	2.34%	76.55%	1448.60%	-95.67%	134.50%	-79.06%	408.75%	-16.95%	-80.04%	595.35%	-67.97%	-196.42%	-273.46%	-54.64%	31.83%	18.46%	-35.53%	249.83%	-71.24%	35.07%	50.89%	54.72%	-4745.23%	-103.24%	-42.73%	-128.66%	719.26%	90.53%	-92.43%	597.93%	-58.05%	-343.21%	-370.82%	-162.47%	33.86%
net income margin %	-Infinity%	-Infinity%	-Infinity%	Infinity%	Infinity%	-Infinity%	-Infinity%	Infinity%	-Infinity%	-202.64%	-71.08%	-13.44%	-36.50%	-53.63%	2.05%	10.07%	21.96%	Infinity%	-Infinity%	Infinity%	-Infinity%	-Infinity%	-Infinity%	-Infinity%	-Infinity%	NaN%	NaN%	-Infinity%	-Infinity%	NaN%	NaN%	-Infinity%	-Infinity%	-Infinity%	-Infinity%	-Infinity%	-Infinity%	-Infinity%	-Infinity%	-Infinity%	-Infinity%	-Infinity%	-Infinity%	-Infinity%	Infinity%	-Infinity%	-Infinity%	-Infinity%	-Infinity%	-Infinity%	-Infinity%	-Infinity%	-Infinity%	-Infinity%	-Infinity%	Infinity%	-Infinity%	-Infinity%	Infinity%	Infinity%	Infinity%	Infinity%	Infinity%	Infinity%	-Infinity%	Infinity%	-Infinity%	-Infinity%
preferred dividends	-1,875	-1,875	-1,875	-1,875	-1,875	-1,875	-1,875	-1,875	-1,875	-1,875	-1,875	-1,875	-1,875	-11,820	-11,819	-11,819	-11,819	-11,707	-12,162	-12,162	-12,162	-12,162	-12,162	-12,162	-12,162	-12,162	-12,162	-12,162	-12,162	-12,162	-12,162	-12,162	-12,162	-12,162	-12,162	-12,162	-12,162	-12,162	-12,162	-12,162		-12,162	-12,162	-12,162
net income available to common shareholders	-11,296,365			179,680
net income per share
basic	-0.08	-0.01	-0.04																							-0.003	-0.02	-0.01		0.003	0.02			-0.003				-0.005	-0.01													-0.01
diluted	-0.08	-0.01	-0.04																							-0.003	-0.02	-0.01		0.003	0.02			-0.003				-0.005	-0.01													-0.01
weighted-average shares outstanding:
basic	141,612,253	123,635,364	123,412,910	118,261,366	113,703,415	108,591,429	108,438,984	108,438,984	107,908,306	107,551,931	107,647,317	107,647,317	107,260,472	106,287,359	106,293,842	106,240,361	106,240,361			106,315,419	92,711,336			70,177,677	69,697,150	69,004,897	69,224,297	68,721,070	68,394,204	67,978,132	68,227,171	67,959,175	67,488,063		67,488,153	67,488,153	67,183,466		66,866,278	66,866,278	66,509,685		66,248,887	63,425,109	66,045,891		65,689,496	63,425,109		62,281,449	62,621,726	61,912,660		61,896,726	61,786,822	61,786,822	60,523,440	58,855,348	59,150,784	59,150,784	57,164,492	54,356,693	54,953,914	53,871,664
diluted	141,612,253	123,635,364	123,412,910	127,223,435	122,298,290	108,591,429	108,438,984	108,943,126	107,908,306	107,551,931	107,647,317	107,647,317	107,260,472	106,287,359	106,293,842	106,240,361	106,389,761			108,696,704	92,711,336			70,177,677	69,697,150	69,004,897	69,224,297	68,721,070	68,394,204	68,097,924	68,373,471	67,959,175	67,488,063		67,488,153	67,488,153	67,183,466		66,866,278	66,866,278	66,509,685		66,248,887	63,425,109	68,523,903		65,689,496	63,425,109		62,281,449	62,621,726	61,912,660		61,896,726	61,786,822	62,427,710	60,523,440	68,136,200	59,692,102	61,556,430	57,426,529	54,544,357	55,198,358	54,514,739
loss on sale or disposal of property, plant and equipment		60,066	-8,216		-500	9,855	-16,252
gain on lease termination			-469,822
trademark and licensing income		6,334.25	7,867	6,627	10,843	6,706	6,553	8,360	6,368	6,984	6,117	11,381	7,525	4,828	4,899	60,775
income before income taxes		-286,905	-4,780,700	181,555	546,524																									-129,329	1,267,447			-463,571	-262,565	-16,955	-391,303	-292,219	-385,567	-144,670	-188,640	-944,907	-135,890	-424,272	440,028	-253,684	-559,329	-424,272		-555,582	-158,813	-322,757	-408,825	-29,529	-175,125	3,770	-190,544	-121,762	708,073	86,428	69,789
net loss available to common shareholders		-288,780	-4,782,575
other miscellaneous income				151		-29,005	-2,364	-2,381	-2,372	3,248	-2,740	-5,538	74,975
other income:
net income available to common stockholders					544,649			200,917		-3,562,185	-1,646,403	-338,340	-808,859	-773,432	38,583	349,404	774,432			324,979		-1,722,561	-1,005,402	-286,445		-449,644.5	-580,754	-498,201		158,433.75	1,255,285	-134,947		-176,827.5	-274,727	-29,117		-294,705	-809,219	-168,832		17,472.25	-148,052	-436,434
income from continuing operations before income taxes						-163,175	-683,097	-55,704	86,101
income from continuing operations						-163,175	-683,097	-55,704	86,101
discontinued operations:
loss from discontinued operations before income taxes						-48,696.25	-44,412		-408,869
loss from discontinued operations						-48,696.25	-44,412		-408,869
net loss available to common stockholders						-884,794	-729,384		-324,643									25,403	-111,394		-347,650				-321,044				-719,622				-486,602				-403,465
basic and diluted earnings per common share:
income from discontinued operations								258,496
loss on disposal of property, plant and equipment									17,494
income from discontinued operations before income taxes								258,496
revenue										1,756,977	2,313,491	2,503,573	2,210,844	1,420,096	2,463,984	3,587,925	3,580,306
yoy										23.72%	-6.11%	-30.22%	-38.25%
qoq										-24.06%	-7.59%	13.24%	55.68%	-42.37%	-31.33%	0.21%
cost of revenue										2,082,125.75	3,374,563	2,207,677	2,746,263	1,709,018	2,033,066	2,865,515	2,440,918
operating expenses
other income
change in fair value of investments														-29,824.5	-25,840	-93,458
net income per share
basic and diluted										-0.008	-0.02		-0.01	0.003			0.01					-0.03	-0.01
other operating and exploration expenses														96,371	91,405
legal and professional fees														39,219	93,678	47,927
interest expense														-4,871	-4,207	-3,081	-2,982	-1,814	-590	-880	-2,255	-3,054	-3,750	-6,439	-4,748	-7,184	-24,444	-24,228	-22,488	-23,807	-27,516	-24,814	-23,833	-26,211	-25,960	-27,154	-27,650	-103,592	-28,343	-28,855				-649	-426	-8	-348	-649	-114	-865	-922	-35,540	-1,461	-529	-2,162		-4,333	-1,051	-2,569			-1,902	2,405	-3,123	-6,890	-378	892	-3
gain on forgiveness – cares act debt
gain on settlement of hillgrove advance																				113,422
interest income																	9,654	8,800.5	13,320	13,389	8,493	213.5	19	31	804	197.75	19	31	741	15	19	268	562	16	19	267	571	16	19	220	1,183	-152	2,059	31	3,168	2,089	3,038	31	2,758	31	674	128	3,089	1,712	2,789	1,493	2,054	879	248	1,526	916
site care and maintenance expenses																		46,009.25
loss on abandonment of mineral properties																						79,625.5	318,502
gain on forgiveness of cares act debt																				443,400
grant income																						2,500		10,000
net income per share
common stock:
basic and diluted																													-0.01				-0.01				-0.01								0.01				-0.01				-0.01													-0.003
weighted-average shares outstanding:
basic and diluted																		102,835,574	106,117,844			72,513,814	73,240,218											67,413,025				66,781,757											63,224,806				61,896,726												53,327,290
factoring expense																						-1,199.75	-1,408	-1,399	-1,992	-1,519	-2,706	-1,424	-1,946	-1,477	-1,154	-938	-1,400	-1,282	-12,104	-11,706	-10,900	-10,488	-9,259	-7,909	-7,526	-7,200	-14,233	-12,987	-8,354	-1,374	-20,014	-12,987	-14,989	-18,827	-9,765	-21,363	-21,816	-7,193	-19,563	-23,895	-27,448	-28,206	-52,586	-38,721	-34,693	-203,180	38,444	30,481	15,148	27,394	18,878	28,189
gain on plant acquisition																															-1,500,000
gain on tax settlement																														-332,332	443,110
foreign exchange loss																																				-10,191
net income before income taxes																										-440,522.75	-568,592
foreign exchange gain																															-12,752	62,752	-50,000	-12,250	2,642		-41,451
operating expenses):
hillgrove advance - earned credit																																						-10,937	-32,813	-52,588	-23,991
provision for income tax																																						-105,872.5	-411,490	-12,000
gain on liability adjustment																																										197			927,018
gain on sale of assets
gain on sale of equipment																																										10,400							-5,450
income tax provision
hillgrove deferred revenue																																										-25,381.75	-43,388
uncollectible accounts																																										-4,667	-18,668
total other expense																																										-11,512.5	-30,842			-10,818.25	-17,324			-13,179.25	-10,013
common stock:
basic																																												-0.01		-0.005		-0.01		-0.01									0.01
diluted																																												-0.01		-0.005		-0.01		-0.01									0.01
income tax benefit																																																		-57,362.75		-229,451		18,577.75			74,311
operating income:
gain on sale of asset																																													5,200
gain from operations																																													445,640
gain on sale of equpment																																														-1,362.5
gross loss																																																-138,857
total other																																																								-22,402	-29,727	-31,469.5	-54,907	-37,195	-33,777
common stock:
basic and diluted																													-0.01				-0.01				-0.01								0.01				-0.01				-0.01													-0.003
diluted																																												-0.01		-0.005		-0.01		-0.01									0.01
mexico impairment loss
mineral exploration expense																																																												96,033	67,653
net income per share
basic and diluted										-0.008	-0.02		-0.01	0.003			0.01					-0.03	-0.01
diluted	-0.08	-0.01	-0.04																							-0.003	-0.02	-0.01		0.003	0.02			-0.003				-0.005	-0.01													-0.01
antimony division - montana
cost of sales:
production costs																																																														814,305.5	1,278,840	1,209,529	768,853	453,249	547,402	384,354
depreciation																																																														5,182.25	7,937	7,213	5,579	31,083	27,965	6,440
freight and delivery																																																														42,453.5	75,887	47,225	46,702	33,993	30,599	28,488
direct sales expense																																																														8,437.5	11,250	11,250	11,250	13,125	11,250	11,250
total cost of sales																																																														884,730.75	1,392,161	1,298,049	848,713	549,078	637,874	452,078
gross profit - antimony																																																														223,275.25	507,308	231,426	154,367	160,484	163,727	129,130
zeolite division - idaho
royalties																																																														50,283	81,229	71,613	48,290	59,290	53,208	46,157
gross profit - zeolite																																																														76,009.25	182,149	105,467	16,421	43,370	25,005	15,636
total revenues - combined																																																														1,541,183	2,659,733	2,090,173	1,414,826	1,165,926	1,212,970	928,991
total cost of sales - combined																																																														1,241,898.5	1,970,276	1,753,280	1,244,038	962,072	1,024,238	784,225
gross profit - combined																																																														299,284.5	689,457	336,893	170,788	203,854	188,732	144,766
other operating expenses:
antimony division - mexico start-up costs																																																														72,987.75	195,013	27,279	125,719
antimony division - mexico depreciation																																																														25,707	46,768
antimony division - mexico impairment loss																																																														49,825.5	199,302
corporate general and administrative																																																														79,827.75	121,710	77,673	119,928	77,386.75	101,049	80,037
exploration expense																																																														250			1,000	-207,724	117,631	73,684
other expenses:
other expenses																																																														19,116.25	40,849	27,358	8,258	-10,056	19,770	28,186
antimony division
zeolite division
expired exclusivity contract
gain on sale of properties, plants and equipment
other operating (icome) expenses																																																																		143,950	218,680	153,721
income (loss) from operations																																																																		21,004	-29,948	-8,955
weighted average shares outstanding:
basic																																																																		49,855,229	51,061,186	46,595,843
diluted																																																																		49,855,229	51,561,186	46,595,843
diluted																																																																		11,508,326.75	46,595,843
weighted average shares outstanding:
basic																																																																		49,855,229	51,061,186	46,595,843
diluted																																																																		49,855,229	51,561,186	46,595,843

Balance Sheets:

Quarterly

Annual

Unit: USD	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31	2019-12-31	2019-09-30	2019-06-30	2019-03-31	2018-12-31	2018-09-30	2018-06-30	2018-03-31	2017-12-31	2017-09-30	2017-06-30	2017-03-31	2016-12-31	2016-09-30	2016-06-30	2016-03-31	2015-12-31	2015-09-30	2015-06-30	2015-03-31	2014-12-31	2014-09-30	2014-06-30	2014-03-31	2013-12-31	2013-09-30	2013-06-30	2013-03-31	2012-12-31	2012-09-30	2012-06-30	2012-03-31	2011-12-31	2011-09-30	2011-06-30	2011-03-31	2011-03-25	2010-12-31	2010-09-30	2010-06-30	2010-03-31	2009-12-31	2009-09-30	2009-06-30

assets
current assets
cash and cash equivalents	3,220,400	30,494,320	18,338,679	5,708,660	18,746,429	18,172,120	12,969,132	12,391,431	11,941,298	11,899,574	12,864,992	13,686,927	15,361,064	19,060,378	7,658,810	8,312,469	21,334,353	21,363,048	21,563,500	22,364,607	23,042,330	665,102	1,435,225	123,415	23,068	115,506	71,758	45,762	43,504	56,650	519,282	15,878	12,381	27,987	27,576	24,550	11,129	10,057	43,318	82,942	137,664	133,543	203,324	74,125	136,086	123,683	538,174	1,571,476	4,851	20,343	84,842	365,694	393,294	1,000,811	2,376,701	3,444,003	1,413,583	5,427	511,070	314,278	1,543,176		448,861	41,267	38,518	96,083	180,613	23,422	92,900
investment in debt securities held to maturity	4,620,170	4,577,706
accounts receivable	2,512,957	4,213,305	1,898,184	2,543,413	1,973,286	1,156,564	791,557	1,393,760	1,057,742	625,256	1,390,437	1,307,974	1,704,276	784,457	1,450,314	1,604,660	1,475,853	891,314	722,727	601,315	537,567	238,634	222,054	233,636	229,692	284,453	322,940	417,005	335,186	438,391	574,216	461,291	412,546	362,579	496,397	541,284	554,380	552,119					757,444	899,831	535,756	454,674	985,546	754,074	872,861	576,021
government grant receivable	12,848,246
inventories	22,026,820	12,522,009	8,413,161	6,812,527	3,991,111	1,245,724	966,814	462,354	653,010	1,386,109	1,876,555	2,350,305	1,610,216	1,375,068	827,958	590,204	1,026,980	1,055,420	733,956	566,711	717,750	650,213	565,050	586,354	642,893	626,244	708,074	723,688	887,648	755,261	716,896	712,696	641,094	914,709	939,880	806,441	911,023	855,637	738,118	905,702	950,084	1,094,238	2,210,028	2,316,266	2,307,164	1,433,539	1,132,915	1,144,036	680,685	1,034,770	879,605	878,431	1,014,732	1,192,189	1,454,633	1,077,271	1,461,149	1,066,813	1,242,326	764,849	216,993		143,291	523,826	579,362	176,931	197,436	127,993	145,650
prepaid expenses and other current assets	734,552	434,842	1,877,249	1,353,208	127,589	104,161	177,283	291,229	117,167	92,369	236,966	377,824		137,599	187,937
note receivable	2,445,762	2,500,000
total current assets	48,408,907	54,742,182	31,797,939	17,676,473	24,838,415	20,678,569	15,001,603	14,611,788	14,006,543	14,076,206	16,628,806	17,982,886	19,214,863	21,617,359	23,357,782	24,126,852	24,096,396	23,568,992	23,064,211	23,576,661	24,604,720	1,808,161	2,476,542	1,197,617	1,149,865	1,279,755	1,356,324	1,440,007	1,519,890	1,903,256	2,063,348	1,442,819	1,318,738	1,562,270	1,740,041	1,655,321	1,733,777	1,692,555	1,717,878	2,176,971	2,326,089	2,136,326	3,734,961	3,982,004	3,611,061	2,303,669	2,955,794	3,788,287	1,887,664	1,910,564	1,923,128	2,227,287	2,538,291	3,103,128	5,094,397	5,749,111	4,157,872	2,816,981	2,981,234	2,687,065	2,808,241		1,848,825	884,936	974,821	490,232	539,814	391,944	334,916
property, plant and equipment	46,668,672	42,374,839	28,121,338	19,725,995	13,471,988
operating lease right-of-use assets	38,223	48,106	36,288	275,627	410,573
investment in debt securities held to maturity - noncurrent	15,922,926	15,773,251
investment in equity securities	36,432,898	40,494,328
investment in joint venture	83,874
restricted cash for reclamation bonds	163,778	162,756	131,402	99,764	99,290	98,778	98,234	55,060	55,060	55,061	57,288	57,288	57,288	57,288	57,283	57,281	57,281	57,281	57,275	57,275	57,275	57,275	57,261	57,261	57,261	57,261	57,248	57,247	57,247	57,247	57,234	63,345	63,345	63,345	63,275	63,274	63,274	63,274	76,014	76,012	76,012	76,012	75,755	75,754	75,754	75,754	75,502	75,501	75,501	75,501	75,253	75,251	75,251	75,251	74,782	74,777	74,777	74,777	74,320	74,311	74,311		74,311	73,935	73,923	73,916	73,916	73,199	73,179
other assets	330,207						20,217	20,217	18,098																										32,520	32,520	362,370	314,203	32,520	32,520	17,530	17,530	15,484	612,882	671,999	653,805	574,420	552,826	552,230	509,281	815,934	562,973	515,183	498,496	155,036	128,686	122,036	54,766	94,767	99,949	113,536		94,766
total assets	148,049,485	153,925,669	79,882,341	47,498,322	39,496,778	34,642,602	29,753,047	28,929,240	28,005,087	28,094,995	30,926,730	32,269,313	32,861,759	34,700,450	35,471,993	35,756,017	35,539,545	35,002,727	34,537,039	34,756,123	35,895,241	13,299,502	14,115,298	13,406,307	13,431,992	13,693,975	16,973,326	17,119,227	17,297,070	17,557,123	17,451,374	16,745,467	16,750,574	17,131,254	17,539,162	17,533,395	17,719,311	17,765,998	17,705,987	18,234,739	18,458,869	18,260,201	19,710,027	18,655,452	18,194,262	16,545,031	16,803,881	17,086,207	15,036,215	14,890,991	13,881,392	14,709,103	14,185,465	14,442,908	13,666,240	13,437,010	11,141,139	8,993,528	8,771,900	7,870,487	6,896,712		5,862,902	4,769,507	4,718,595	4,052,849	4,017,884	3,638,954	3,485,028
liabilities and stockholders’ equity
current liabilities
accounts payable	9,672,375	6,924,518	4,218,043	5,746,709	3,206,080	1,545,708	1,212,397	544,100	403,441	456,935	606,300	407,130	835,652	628,803	462,261	679,597	1,107,574	1,385,752	1,252,846	1,357,304	1,294,514	1,876,874	2,076,794	2,072,609	2,304,449	2,328,977	2,060,557	2,071,572	2,045,402	1,926,320	2,304,976	2,367,656	2,292,559	2,276,357	2,199,458	1,864,415	2,121,759	1,797,251	1,658,225	1,730,610	1,960,029	1,629,972	2,016,380	2,297,779	1,942,741	1,821,673	1,875,028	2,555,212	1,943,813	1,734,767	1,847,681	1,676,716	1,083,350	1,181,223	970,845	829,329	1,050,390	994,940	1,127,649	928,028	580,677		410,242	508,550	665,342	444,667	457,425	529,753	568,568
accrued liabilities	3,388,210	2,937,842	1,581,627	1,251,778	613,159	1,427,146	164,917	157,001	117,822	133,841	224,151	224,510	169,422	201,149	622,403	685,918	624,817	621,873	571,209	542,699	554,628	635,626
accrued liabilities - directors	140,958	143,931	89,530	88,750	123,250	141,287	159,165	161,249	167,059	124,810
current portion of operating lease liabilities	27,477	34,103	28,990	592,695	452,826
current portion of long-term debt	138,140	136,942	135,754	134,577	133,409
total current liabilities	13,367,160	10,177,336	6,261,389	7,997,032	4,718,226	4,006,389	2,404,802	1,252,164	906,122	897,458	1,279,696	977,947	1,209,240	2,219,870	1,279,650	1,460,946	1,744,678	2,020,855	1,824,055	1,942,297	3,030,427	4,477,543	3,588,963	3,719,938	3,939,675	3,975,681	4,178,761	4,180,942	3,855,525	3,517,618	3,686,351	4,209,889	4,062,455	3,934,726	3,880,431	3,598,492	3,754,101	3,382,123	3,214,473	2,936,312	2,948,379	2,429,830	3,092,124	3,243,915	2,832,306	2,292,640	2,587,376	3,450,052	3,039,513	2,479,341	2,445,823	2,408,189	2,009,448	1,803,396	1,687,791	1,260,856	1,536,270	1,595,433	1,519,884	1,333,443	961,847		784,322	943,813	1,124,622	806,065	848,443	945,917	895,186
operating lease liabilities, net of current portion	10,746	14,003	7,298	117,722	294,989
long-term debt	23,495	58,483	93,167	127,550	161,636	195,425	228,921	262,127			179,892	183,063	193,410	217,855	241,932	265,636	198,806	201,920		33,200	33,138	34,304	46,264	55,983	66,388	76,762	876,073	918,435	968,443	1,027,730	1,001,563	1,084,827	1,159,895	1,239,126	1,282,981	1,341,780	1,400,315	1,472,869	1,514,318	1,530,225	1,571,927	1,717,745	1,665,749	632,047	623,023	715,328	713,306	727,006	767,712	1,002,215	263,522	979,735	990,088	1,044,140				158,218
asset retirement obligations	2,753,172	2,720,658	1,769,557	1,750,075	1,730,591	1,711,108	1,156,374	1,138,102	1,119,832
total liabilities	16,154,573	12,970,480	8,131,411	9,992,379	6,905,442	6,041,929	4,625,998	3,227,401	2,600,962	2,574,027	1,845,452	1,543,507	1,799,488	2,831,195	1,850,416	2,239,739	2,384,490	2,633,924	2,205,346	2,435,198	3,938,541	6,113,113	5,218,510	5,329,347	5,211,232	5,226,833	6,568,261	6,576,892	6,443,696	6,132,289	6,229,543	6,791,083	6,848,405	6,754,645	6,698,982	6,430,650	6,599,611	6,423,745	6,250,867	5,982,562	6,050,056	5,800,248	6,305,167	5,289,700	4,629,835	3,549,497	3,554,662	4,429,828	4,216,815	3,889,136	3,036,915	3,750,234	3,251,086	3,097,076	2,072,314	1,640,879	2,026,595	2,225,155	1,800,581	1,626,869	1,156,828		974,229	1,142,507	1,325,911	1,024,246	1,054,653	1,113,918	1,052,208
commitments and contingencies
stockholders’ equity
preferred stock 0.01 par value...
series a - no shares issued and outstanding
series b - 750,000 shares issued and outstanding	7,500	7,500	7,500	7,500	7,500
series c - 177,904 shares issued and outstanding	1,779	1,779	1,779	1,779	1,779
series d - no shares issued and outstanding
common stock, 0.01 par value...	1,437,390	1,400,423	1,303,382	1,192,010	1,161,092	1,129,512	1,084,389	1,084,389	1,084,389	1,076,472	1,076,472	1,076,472	1,076,472						1,061,177
treasury stock	-6,372,556	-574,153	-510,675
additional paid-in capital	193,603,838	185,608,189	116,150,588	76,725,598	72,023,464	68,610,905	64,299,485	64,146,766	64,051,844	63,853,836	63,853,836	63,853,836	63,853,836	64,052,630	64,053,827	63,991,459	63,991,459	63,991,459	63,992,101	63,883,227	63,856,560	39,050,899	39,050,899	37,295,259	37,167,730	37,107,730	37,134,853	36,712,572	36,540,874	36,406,874	36,406,874	36,406,874	36,239,264	36,239,264	36,239,264	36,239,264	36,239,264	36,074,733	36,022,733	36,022,733	36,022,733	35,890,733	35,890,733	35,866,734	35,866,733	35,740,671	35,740,672	34,598,622	32,204,714	32,030,249	31,322,632	31,312,469	30,743,022	30,745,650	30,723,895	30,750,974	28,082,985	25,635,129	25,635,129	25,638,159	25,268,307		24,505,331	24,097,975	23,925,308	23,723,443	23,604,625	23,101,137	22,965,932
accumulated deficit	-56,783,039	-45,488,549	-45,201,644	-40,420,944	-40,602,499	-41,149,023	-40,266,104	-39,538,595	-39,741,387	-39,418,619	-35,858,309	-34,213,781	-33,877,316	-33,070,332	-31,520,990	-31,563,788	-31,925,011	-32,711,263	-32,748,373	-32,649,141	-32,986,282	-32,650,794	-30,940,395	-29,947,155	-29,672,872	-29,363,990	-27,453,190	-26,884,598	-26,398,559	-25,691,099	-25,894,102	-27,161,549	-27,038,764	-26,564,324	-26,100,753	-25,838,188	-25,821,233	-25,429,930	-25,263,063	-24,466,006	-24,309,370	-24,120,730	-23,175,823	-23,039,932	-22,842,171	-23,282,199	-23,028,515	-22,469,185	-22,044,914	-21,686,744	-21,131,160	-21,006,605	-20,454,397	-20,045,572	-19,774,625	-19,599,499	-19,603,269	-19,487,036	-19,284,090	-19,992,166	-20,078,594		-20,123,956	-20,722,887	-20,808,702	-21,013,285	-20,929,169	-20,960,229	-20,910,511
total stockholders’ equity	131,894,912	140,955,189			32,591,336						29,081,278	30,725,806	31,062,271	31,869,255	33,621,577	33,516,278	33,155,055																																																			2,525,036
total liabilities and stockholders’ equity	148,049,485	153,925,669			39,496,778						30,926,730	32,269,313	32,861,759	34,700,450	35,471,993	35,756,017	35,539,545																																																			3,638,954
iva receivable and other assets		330,207	908,647	891,879	676,512	408,519				509,237	1,307,094	1,218,500	1,070,955	897,679	847,768	329,163	283,744	242,721	239,084	223,874	206,818	208,472	159,992	214,063	168,028	170,111	329,947	367,769	403,466	369,448	464,334	384,677	418,351	372,742
investment securities held to maturity			1,270,666	1,258,665
investment securities held to maturity - noncurrent			18,886,727	8,828,584
liabilities and stockholders' equity
royalties payable			207,445	182,523	189,502	133,434	105,174	113,917	52,527	153,429	107,937	45,359	15,884	435,075
stockholders' equity
total stockholders' equity			71,750,930	37,505,943		28,600,673	25,127,049	25,701,839	25,404,125	25,520,968								32,368,803	32,331,693	32,320,925	31,956,700	7,186,389	8,896,788	8,076,960	8,220,760	8,467,142	10,405,065	10,542,335	10,853,374	11,424,834	11,221,831	9,954,384	9,902,169	10,376,609	10,840,180	11,102,745	11,119,700	11,342,253	11,455,120	12,252,177	12,408,813	12,459,953	13,404,860	13,365,752	13,564,427	12,995,534	13,249,219	12,656,379	10,819,400	11,001,855	10,844,477	10,958,869	10,934,379	11,345,832	11,593,926	11,796,131	9,114,544	6,768,373	6,971,319	6,243,618	5,739,884		4,888,673	3,627,000	3,392,684	3,028,603	2,963,231		2,432,820
total liabilities and stockholders' equity			79,882,341	47,498,322		34,642,602	29,753,047	28,929,240	28,005,087	28,094,995								35,002,727	34,537,039	34,756,123	35,895,241	13,299,502	14,115,298	13,406,307	13,431,992	13,693,975	16,973,326	17,119,227	17,297,070	17,557,123	17,451,374	16,745,467	16,750,574	17,131,254	17,539,162	17,533,395	17,719,311	17,765,998	17,705,987	18,234,739	18,458,869	18,260,201	19,710,027	18,655,452	18,194,262	16,545,031	16,803,881	17,086,207	15,036,215	14,890,991	13,881,392	14,709,103	14,185,465	14,442,908	13,666,240	13,437,010	11,141,139	8,993,528	8,771,900	7,870,487	6,896,712		5,862,902	4,769,507	4,718,595	4,052,849	4,017,884		3,485,028
certificates of deposit							22,257	22,216	22,216	72,898	259,856	259,856	259,856	259,857	259,210	259,210	259,210	259,210	44,028	44,028	254,873	254,212	254,213	254,212	254,212	253,552	253,552	253,552	253,552	252,954	252,954	252,954	252,717	252,298	252,298	252,298	252,062	251,641	251,641	251,641	251,452	250,414	250,414	250,180	250,180	249,147	249,147	248,915	248,915	246,565	246,565	245,940	245,940	243,616	242,800	242,800	242,800
properties, plants and equipment						12,891,447	7,751,348	7,798,594	7,709,812	13,454,491	12,933,542	13,010,639	12,518,653	12,128,124	11,209,160	11,242,721	11,102,124	11,133,733	11,176,469	10,898,313	11,026,428	11,225,594	11,421,503	11,937,366	12,056,838	12,186,848	15,229,807	15,254,204	15,316,467	15,227,172	14,866,458	14,854,626	14,950,140	15,132,897	15,338,206	15,417,160	15,559,890	15,695,966	15,879,575	15,949,236	16,039,238	16,030,333	15,883,827	13,984,812	13,835,448	13,511,803	13,198,165	12,669,593	12,520,820	12,395,645	11,067,077	11,843,592	10,867,113	10,576,406	8,342,025	7,484,436	6,786,454	6,047,004	5,621,579	5,009,162	3,900,624		3,845,000	3,810,636	3,669,851	3,488,701	3,404,154	3,173,811	3,076,933
operating lease right-of-use asset						565,289	764,035
current portion of operating lease liability						626,562	483,211
long-term debt, current portion						132,252	131,105	129,967	7,170	28,443	62,064	82,573	95,573	94,150	92,738	91,347	12,287	13,230		25,300	40,770	52,122	55,956	55,875	55,802																										141,611	378,033	469,154
noncurrent liabilities:
noncurrent operating lease liability						129,007	299,435
stock payable to directors								38,542	38,542	38,542
series a: 0 shares issued and outstanding
series b: 750,000 shares issued and outstanding						7,500	7,500	7,500	7,500	7,500	7,500	7,500	7,500	7,500	7,500	7,500	7,500		7,500
series c: 177,904 shares issued and outstanding						1,779	1,779	1,779	1,779	1,779	1,779	1,779	1,779	1,779	1,779	1,779	1,779		1,779
series d: 0 shares issued and outstanding
current assets held for sale							74,560	50,798	215,110
noncurrent assets held for sale							6,117,610
current liabilities held for sale							148,833	145,930	158,103
noncurrent liabilities held for sale							536,466
non-current assets held for sale								6,443,581	6,215,574
non-current liabilities held for sale								536,466	536,466
dividends payable														787,730
asset retirement obligations and accrued reclamation costs										1,638,027	342,114	338,747	335,379		328,834	325,657	300,381	298,649	296,916	293,451	293,451	291,719	289,986	288,254	286,522	283,868	282,331	280,794	279,257	277,720	276,183	274,646	273,109	271,572	270,124	268,677	267,229	265,782	264,418	263,054	261,691	260,327	259,043	257,759	256,474	255,190	253,980	252,770	259,590	257,580
series d: 0 and 1,692,672 shares issued and outstanding
shares to be returned to treasury														-202,980
current assets:
current liabilities:
accrued liabilities – directors											279,244	218,375
non-current liabilities:
stock payable to directors for services											43,750	43,750	61,459	61,459		187,500	140,625	112,500	84,375	166,250	138,125	110,000	93,750	65,625	162,500	134,375	96,875	62,500	206,250	175,000				175,000				168,750				137,500	112,500	75,000	37,500	125,000			150,000	150,000								230,004
stockholders’ equity:
preferred stock, 0.01 par value...
prepaids expenses and other current assets													279,451
accrued liabilities – directors and related parties													92,709		102,248
accrued liabilities – officers and directors														72,963
asset retirement obligation and accrued reclamation costs														332,011																																					255,570	253,560	251,550
series d: 1,692,672 shares issued and outstanding														16,926	16,926	16,926	16,926
common stock, 0.001 par value...														1,063,732	1,062,535	1,062,402
investments															12,973,553	13,299,393
prepaid expenses																60,916
payable to related parties																4,084						227,432	253,564	272,054																																												11,664	7,252
common stock, .001 par value...																	1,062,402
checks issued and payable																						86,685	14,754	160,163	73,735	17,633	31,705	113,028	45,637	46,482	41,820	110,578	11,045	28,248	48,408	22,906	14,163	35,682																				113,908			13,371				24,929	46,396	17,142	38,863	31,643
notes payable to bank																						100,000	150,796	165,931	199,554	197,066	198,228	199,998	113,125	183,917	100,000	191,009	97,117	192,565	103,026	192,144	183,302	167,317	100,000	126,505	85,760	130,672			71,906			100,000	154,503	138,520
export tax assessment payable																						1,120,730
hillgrove advances payable																					1,134,221	378,074	378,074	378,074	378,074	378,074	1,134,221	1,134,221	1,134,221	1,134,221	1,134,196	1,134,221	1,134,196	1,134,221	1,134,196	1,134,201	1,134,216	1,134,221	1,145,158	1,177,971	1,230,559	1,254,846	1,175,751	1,080,979	880,532	161,339
cares act note payable																					443,400	443,400
stockholders' equity:
series a: -0- shares issued and outstanding
series d: 1,692,672 and 1,751,005 shares issued and outstanding
(liquidation preference 4,979,632 and 5,084,770
respectively)																		16,926			7,500	7,500	7,500	7,500	7,500	7,500	7,500	7,500	7,500	7,500	7,500	7,500	7,500	7,500	7,500	7,500	7,500	7,500	7,500	7,500	7,500	7,500	7,500	7,500	7,500	7,500			7,500	7,500				7,500				7,500
106,240,361 and 75,949,757 shares issued and outstanding, respectively																		1,062,402
payables to related party																				16,994	6,294				297,799	359,309		356,902	247,731	93,567			105,904	22,668
series d: 1,751,005 shares issued and outstanding																			17,509
106,005,234 and 75,949,757 shares issued and outstanding, respectively																				1,060,051
other current assets																					52,200													4,697	23,890	30,748	5,183	23,101	164,684	264,835	118,865	235,458	313,751	441,602	381,875	42,626	50,012	69,786	80,352	32,865	48,696	216,527	208,203	170,529	57,659	57,660	97,315	56,208	106,451	42,025	354,636		18,255
(liquidation preference 945,000 and 937,500
(liquidation preference 5,084,770 and 5,043,622
105,963,567 and 75,949,757 shares issued and outstanding, respectively																					1,059,634
75,949,757 and 69,661,436 shares issued and outstanding, respectively																						759,496	759,496
due to factor																							5,848	11,492	17,227	10,880	59,104	13,804	5,440	16,524	16,048	5,440	12,750	10,880	163,737	170,870	146,011	150,399	132,893	107,964	97,865	13,782	272,889	154,791	154,524	13,314	326,272	173,096	218,223	177,701	181,018	202,635	304,730	23,536	240,446
accrued payroll, taxes and interest																							215,973	189,777	222,653	260,800	200,362	241,882	262,463	159,037	135,299	211,703	195,298	185,283	162,833	173,333	193,280	213,695	225,462	288,670	190,680	221,446	137,292	168,668	131,831	135,245	110,060	190,982	138,865	124,937	100,372	100,730	101,052	89,541	93,105	98,409	150,288	141,928	78,201	103,342	99,232		90,503	111,070	112,482	93,877	83,857
other accrued liabilities																							404,804	381,563	357,982	334,208	401,376	389,693	378,010	353,911	330,064	205,412	195,849	168,578	153,273	154,659	128,854	122,968	184,434	215,673	193,053	141,545	109,577	59,717	41,900	38,811	35,990	68,378	53,935	50,745	74,915	18,394	33,982	30,220	32,434	63,696	33,476	119,292	183,804	175,798	189,001		220,128	182,364	174,641	112,886	148,835	41,264	38,318
deferred revenue																							32,400	32,400	32,400	32,400	32,400	32,400	32,400	32,400	32,400	32,400	60,165	60,049	78,730	78,730	78,730	78,730	78,730	78,730	78,730	78,730	212,718	195,007	221,272	115,962	41,515	92,138	92,138	110,138	91,692	30,000			31,668			43,760						65,000	65,000	66,661	73,022	148,612	65,000
note payable-sba																							443,400	443,400
(liquidation preference 937,500 and 930,000
(liquidation preference 5,043,622 and 5,002,473
70,206,899 and 69,661,436 shares issued and outstanding, respectively																								702,068
69,911,436 and 69,661,436 shares issued and outstanding, respectively																									699,114
note receivable - sale of land																														400,000
long-term debt, current portion, net of discount																										56,334	851,766	761,663	725,317	705,460	669,407	632,655	598,658	546,988	495,134	462,524	433,993	391,046	368,563	332,211	309,635	181,287
69,661,436 and 68,227,171 shares issued and outstanding, respectively																										696,614	696,614
payables to related parties																											343,263				56,337	22,678			16,322	16,759	2,048	14,525	42,676	43,949	32,627	32,396	34,942	38,585	20,073	8,357	28,608	86,011	1,466	15,549	8,534	1,681	17,180	17,522	13,382	10,434	46,662	101,974	46,218	42,263	24,897		18,060	22,260	20,800	11,236	10,306
(liquidation preference 930,000 and 922,500
(liquidation preference 5,002,470 and 4,961,324
68,757,354 and 68,227,171 shares issued and outstanding, respectively																												687,573
68,427,171 and 68,227,171 shares issued and outstanding, respectively																													684,271
income taxes payable																																430,358	493,110	443,110	459,510	462,152	451,961	410,510
68,227,171 and 67,488,153 shares issued and outstanding, respectively																														682,271
common stock payable to directors for services																															131,250	87,500	218,750		131,250	87,500	43,750		112,500	75,000	37,500
(liquidation preference 909,375 and 907,500
(liquidation preference 5,014,692 and 4,920,178
68,227,171 and 67,488,063 shares issued and outstanding, respectively																															682,271	682,271
67,488,063 shares issued and outstanding																																	674,881
(liquidation preference 922,500 and 915,000
(liquidation preference 4,961,324 and 4,920,178
67,488,153 and 67,066,278 shares issued and outstanding, respectively																																		674,881	674,881	674,881
foreign value added tax refund receivable																																			365,120	365,120
(liquidation preference 5,014,692 and 4,879,029
67,488,063 and 66,866,278 shares issued and outstanding, respectively																																					674,881
(liquidation preference 915,000 and 907,500
(liquidation preference 4,920,178 and 4,879,029
67,066,278 and 66,316,278 shares issued and outstanding, respectively																																						670,662
accounts receivable, net of 4,031 allowance for doubtful accounts																																							520,117	671,851	868,024	422,673
foreign income tax payable																																							423,490
66,866,278 and 66,316,278 shares issued and outstanding, respectively																																							668,662	668,662	668,662
income tax payable																																								12,000
(liquidation preference 907,500 and 900,000
(liquidation preference 4,879,029 and 4,837,880
66,316,278 and 66,027,453 shares issued and outstanding, respectively																																										663,162	663,162
notes receivable from stock sales																																												-150,000	-149,085		-150,000
note payable to bank																																											92,502	97,297
long-term debt, current																																											215,824	232,071	248,059	159,278	169,903	184,235	399,391	126,984				461,354	305,911	258,988	255,454	79,631	84,012	84,012	54,669		45,389	54,569	61,428	30,342	57,856	79,098	90,559
(liquidation preference 900,000 and 892,500,
66,216,278 and 66,027,453 shares issued and outstanding, respectively																																												662,162	662,162
(liquidation preference 4,837,880 and 4,796,731
66,027,453 and 63,156,206 shares issued and outstanding, respectively																																														660,274	660,274
notes receivable for stock sales																																														-150,000		-150,000
65,015,453 and 63,156,206 shares issued and outstanding, respectively																																																650,154
checks issued and outstanding																																																	37,179
(liquidation preference 892,500 and 885,000,
63,281,206 and 63,156,206 shares issued and outstanding, respectively																																																	632,812
deferred tax asset																																																					39,824	39,824	470,869	470,869	470,869	396,558	471,074	471,074	471,074		493,000
(liquidation preference 4,796,731 and 4,755,582,
63,156,206 and 61,896,726 shares issued and outstanding, respectively																																																		631,562
accounts receivables																																																							491,735	456,508													96,366
for doubtful accounts of 4,031																																																			663,420	520,695	636,298
derivative liability																																																			72,000	108,750
common stock
62,621,726 and 61,896,726 shares issued and outstanding																																																			626,217	626,217
61,896,726 shares issued and outstanding																																																					618,966
for doubtful accounts of 4,031 and 7,600, respectively																																																						456,159
asset retirement and accrued reclamation costs																																																						249,540	247,530	245,520		241,500
(liquidation preference 885,000 and 877,500,
(liquidation preference 4,755,582 and 4,714,433,
61,896,726 and 59,349,300 shares issued and outstanding, respectively																																																						618,966
long-term debt, noncurrent																																																							136,993	134,503	246,815		173,197	185,926	87,481		82,407	91,194	93,789	110,681	98,710	60,501	49,522
series a: no shares issued and outstanding
61,786,822 and 59,349,300 shares issued and outstanding, respectively																																																							617,868	617,868
for doubtful accounts of 4031 and 7600																																																									472,156
accrued reclamation and remediation costs, noncurrent																																																									243,510		107,500	107,500	107,500			107,500	107,500	107,500		107,500	107,500
60,804,010 and 59,349,300 shares issued and outstanding, respectively																																																									608,040
for doubtful accounts of 7,600 both years																																																										1,291,975
(liquidation preference 877,500 and 870,000,
(liquidation preference 4,714,433 and 4,673,284,
59,349,300 and 56,307,382 shares issued and outstanding, respectively																																																										593,492	593,492	593,492
stock subscriptions receivable																																																												-22,655	-60,184		-82,563	-323,730	-293,730	-243,730	-270,000	-156,000	-157,824
for doubtful accounts of 7,600																																																											371,120	1,094,839	222,362
other receivable																																																											279,193
58,356,800 and 56,307,382 shares issued and outstanding, respectively																																																													583,567
john c. lawrence, president																																																														2,009
title of class
series c preferred
series d preferred
3.01
3.02
3.03
3.04
4.01
10.10
10.11
10.12
10.13
10.14
10.15
10.16
10.17
10.18
10.19
10.20
10.21
10.22
10.23
10.24
10.25
10.26
10.27
10.28
10.30
10.31
10.32
10.33
10.34
10.35
10.36
10.37
10.38
10.39
10.40
10.41
10.42
10.43
10.44
10.45
10.46
10.47
10.48
10.49
10.50
10.51
10.52
10.53
10.54
14.0
31.1
32.1
44.1
date: march 25, 2011
signature
/s/ john c. lawrence
john c. lawrence
/s/ leo jackson
leo jackson
/s/ gary d. babbitt
gary d. babbitt
/s/ patrick dugan
patrick dugan
/s/ russell lawrence
russell lawrence
for doubtful accounts of 7,600 and 7,872, respectively																																																															745,418	319,843	356,941	217,218
accrued reclamation costs, noncurrent																																																															107,500				107,500
(liquidation preference and cumulative dividends 870,000
and 862,500, respectively.)																																																															7,500
(liquidation preference and cumulative dividends of 4,673,284
and 4,632,136, repectively)																																																															17,509
56,307,382 and 53,098,769 shares issued and outstanding, respectively.																																																															563,073
the accompanying notes are an integral part of these consolidated financial statements.
(liquidation preference and cumulative dividends of 4,632,136
and 4,632,136, respectively)																																																																17,509		17,509
54,885,435 and 53,098,769 shares issued and outstanding, respectively																																																																548,854
54,302,102 and 53,098,769 shares issued and outstanding, respectively																																																																	543,020
53,538,772 and 53,098,769 shares issued and outstanding, respectively																																																																		535,387
for doubtful accounts of 7,872 and 10,000, respectively																																																																			161,765	240,529
and 4,590,987, repectively)																																																																			17,509
53,098,769 and 45,868,535 shares issued and outstanding, respectively.																																																																			530,987
accrued payroll and payroll taxes																																																																				69,309	67,143
accrued interest payable																																																																				27,354	26,703
convertible note payable to a related party
51,334,091 and 45,868,535 shares issued and outstanding, respectively																																																																				513,340
50,843,535 and 45,868,535 shares issued and outstanding, respectively																																																																					508,435

Cashflow Statements:

Quarterly

Annual

Unit: USD	2026-03-31	2025-12-31	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31	2019-12-31	2019-09-30	2019-06-30	2019-03-31	2018-12-31	2018-09-30	2018-06-30	2018-03-31	2017-12-31	2017-09-30	2017-06-30	2017-03-31	2016-12-31	2016-09-30	2016-06-30	2016-03-31	2015-12-31	2015-09-30	2015-06-30	2015-03-31	2014-12-31	2014-09-30	2014-06-30	2014-03-31	2013-12-31	2013-09-30	2013-06-30	2013-03-31	2012-12-31	2012-09-30	2012-06-30	2012-03-31	2011-12-31	2011-09-30	2011-06-30	2011-03-31	2010-12-31	2010-09-30	2010-06-30	2010-03-31	2009-12-31	2009-09-30

cash flows from operating activities:
net income	-11,294,490		728,079	546,524					-3,560,310	-1,644,528	-336,465	-806,984	-761,612	42,798	361,223	786,252			337,141	-335,488	-1,710,399	-993,240	-274,283	-308,882	-1,910,800	-568,592	-486,039	-707,460	203,003	1,267,447	-122,785	-474,440	-463,571	-262,565	-16,955	-391,303	-166,867	-797,057	-156,636	-188,640			-197,761	440,028					-555,584	-124,553			-270,947	-175,126	3,770	-116,233	-202,946	708,075	86,428	45,363	598,932	85,815	204,583	-84,117	31,060	-49,718
adjustments to reconcile income to net cash from operating activities:
depreciation and amortization	410,459	327,226	559,525	281,970	745,530	119,584	114,486	106,147	245,143	248,961	241,100	224,241	215,230	242,783	231,057	220,150	215,276	223,196	219,944	222,464	218,545	217,650	223,367	226,281			223,273	223,273			175,097	277,562			214,375	215,675				261,150
accretion of asset retirement obligation	32,514	19,483	38,967	19,483	18,268	18,272	18,270	18,271	3,368	3,367	3,368	3,368	3,177	3,177	9,680	1,732	1,733	3,465	0	1,732	1,733	1,732	1,732	2,654	1,537	1,537	1,537	1,537	1,537	1,537	1,537	1,537	1,448	1,447	1,448	1,447	1,364	1,364	1,363	1,364	1,284	1,284	1,285	1,284	1,210	1,210	-6,820	2,010	2,010	2,010	2,010	2,010	2,010	2,010	2,010	2,010
noncash operating lease expense		0	244,510	146,962	198,746
share-based compensation	4,833,965	2,392,933	832,297	245,384	115,022	152,719	94,922	205,925																																																										0
accretion income from investment in debt securities held to maturity	-192,139
paid-in-kind interest from notes receivable	-45,762
gain on sale or disposal of property, plant and equipment	-1,900
equity in losses of joint venture	16,126
write-down of inventory to net realizable value	161,456				2,073							246,792							8,524	57,530
change in allowance for credit losses	156	-15,054	884
unrealized loss on investment in equity securities	4,061,430
changes in operating assets and liabilities:
accounts receivable	1,700,192	-2,300,067	-1,387,733	-816,722	-134,706	618,691	-321,760	-432,486	568,969	-126,023	396,302	-919,819	606,507	154,346	-128,807	-584,539	-168,587	-121,412	-63,748	-298,933	-16,580	11,582	-3,944	54,761	38,487	94,065	-81,819	103,205	135,825	-112,925	-48,745	-49,967	133,818	44,887	13,096	-2,261	-32,002	151,734	196,173	-445,351	316,103	142,387	-378,575	-66,582	530,872	-231,472	118,787	-296,840	87,399	-142,725	115,603	-180,139	35,576	111,362	15,648	819,819	-920,855	723,719	-872,477	523,056	-425,303	37,098	-139,723	-55,453	80,892	-144,163
inventories	-9,666,267	-5,027,901	-5,566,803	-2,745,387	85,972	-557,533	260,298	286,001	-699,568	46,598	-949,535	-481,940	-414,337	-510,837	299,940	28,440	-321,464	-101,191	142,515	-125,067	-85,163	21,304	56,539	-16,649	65,434	15,614	163,960	-132,387	-38,365	-4,200	-71,602	273,615	25,171	-133,439	104,582	-55,386	-117,519	167,584	44,382	144,154	1,115,790	106,238	-9,102	-873,625	-300,624	11,121	-463,351	354,085	-155,165	-1,174	136,301	177,457	262,444	-377,362	383,878	-394,336	175,513	-477,477	-547,856	-73,702	380,535	55,536	-402,431	20,505	-69,443	17,657
prepaid expenses and other current assets	-299,710	1,442,407	-1,249,047	-23,428	73,122	113,946	-174,062	-24,798	144,597	140,858	-98,373	-141,852	50,338
iva receivable and other assets		-722,180	-483,360	-267,993					110,322	-88,594	-147,545	-173,275	-49,911	-518,605	-45,419	-41,023	-3,637	-15,210	35,144	-50,546	-48,480	54,071	-46,035	2,083	159,836			-34,018				-45,609
accounts payable	-2,223,094	731,891	4,201,001	1,660,372	206,523	668,297	140,659	73,294	-149,365	199,170	-428,522	206,849	166,541	-217,335	-427,977	-278,178	132,908	-104,458	62,790	-582,360	-199,920	4,185	-231,840	-24,528	268,420	-11,015	26,170	119,082	-378,656	-62,680	75,097	16,202	76,899	335,043	-257,344	324,508	140,552	-73,910	-229,419	330,057	-1,301,375	-281,399	1,270,006	121,067	-53,355	-680,184	605,684	214,761	126,315	231,190	230,556	-113,623	210,378	141,516	-221,061	55,450	-43,054	199,620	275,523	152,609	-51,498	-177,293	292,739	-31,481	81,569	-51,920
accrued liabilities	450,368	1,222,781	-175,368	-813,987	1,237,729	7,916	39,179	8,481	-78,805	-359	43,583	-31,727	-73,166	-63,515	61,101	2,944	50,664	28,510	-11,929	-80,998
accrued liabilities – directors	-2,973	54,401	-52,537	-18,037	-17,878	-2,084	-5,810	42,249	-148,230	60,869
net cash from operating activities	-12,059,669	-3,470,307	-2,356,986	-1,729,291																													225,452				13,675												186,161	-74,477			137,716
capital expenditures	-12,581,587	-11,739,241	-7,394,073	-862,511																													0				0												0	0			0
free cash flows	-24,641,256	-15,209,548	-9,751,059	-2,591,802																													225,452				13,675												186,161	-74,477			137,716
cash flows from investing activities:
investment in joint venture	-100,000
proceeds from note receivable principal payment	100,000
proceeds from sales of property, plant and equipment	1,900		500	500
purchases of property, plant and equipment	-12,581,587	-11,739,241	-7,394,073	-862,511
net cash from investing activities	-12,579,687	-51,407,433	-17,384,832	-862,011
cash flows from financing activities:
principal payments on long-term debt	-33,790	-33,496	-65,550	-32,632	-32,349	-32,068	-17,798	-21,273													-15,794	-9,638				-27,531				-67,632				-49,603				-94,261				-37,643	-17,589	-14,149		-39,470	-28,738	-31,136		-50,446	-136,233	-46,252		-18,797
proceeds from exercises of stock options	48,624	62,667	55,000
treasury stock acquired	-4,982,634
proceeds from issuance of common stock, net of issuance costs	1,339,446	65,770,618	5,064,483	2,392,317														0	0	23,342,180
proceeds from exercise of warrants	994,812	1,305,175	2,225,411	806,438													2	0	27,084	1,763,619
net cash from financing activities	-2,633,542	67,064,735	7,279,344	3,166,123													-2	-58,500	-1,009,323	24,850,380																					197,911	172,334			3,998	943,499			740,319	280,448			-534,751	47,981	2,140,660	2,328,976	99,672	-3,903	333,123	803,074	577,174	114,118	121,726	113,799	377,283	129,672
net increase in cash and cash equivalents and restricted cash	-27,272,898	12,186,995	-12,462,474	574,821	5,203,532	620,875	450,133	41,723					11,401,573	-653,657	-13,021,884	-28,695
cash and cash equivalents and restricted cash at beginning of period	30,657,076	0	18,270,898	18,270,898	0	0				0	0	19,117,666		0				0	0	722,377	0	0	0	172,767		0	0	113,897		0	0	91,332
cash and cash equivalents and restricted cash at end of period	3,384,178	12,186,995	5,808,424	18,845,719	5,203,532	620,875	450,133	11,996,358		-821,935	-1,674,137	15,418,352		-653,657				-801,107	-677,723	23,099,605	-770,109	1,311,810	100,347	80,329		25,997	2,258	100,751		497,293	3,497	75,726
supplemental disclosure of cash flow information:
interest paid in cash	1,699	2,012	5,243	2,937																																								426
non-cash financing and investing activities:
recognition of operating lease liability and right-of-use asset		22,772	63,416
property and equipment included in accounts payable	4,970,951
net loss		-286,905															37,110																												-253,684	-559,329	-424,272	-358,170				-408,825
adjustments to reconcile loss to net cash from operating activities:
loss on sale or disposal of property, plant and equipment		60,066	-500	-500	9,855
gain on lease termination		0
unrealized gain on investment in equity securities
change in iva receivable reserve
other noncash items					0
stock payable to directors					0
proceeds from redemption of certificates of deposit					22,257	-41	0	50,682									-182	0
purchases of investment in debt securities held to maturity
purchases of equity investment securities
issuance of note receivable
proceeds from sales or disposals of property, plant and equipment
acquisition of treasury stock related to equity awards
equipment purchased with note payable					0	0								0
accretion income from investment securities held to maturity
royalties payable			49,089	56,068	28,260	-8,743	61,390	-100,902	45,492	62,578	29,475	-419,191
purchases of investment securities held to maturity			-9,991,259
adjustments to reconcile net income to net cash from operating activities:
accretion of income from investment securities held to maturity			-95,990
noncash recognition of new operating leases				63,416
adjustments to reconcile net loss to net cash provided (used) by operating activities:
changes in asset retirement obligation estimates
change in allowance for doubtful accounts on accounts receivable
change in iva receivable and other assets
change in operating lease liability					-27,077
net cash provided (used) by operating activities					2,062,173	-37,173				-626,391	-917,704	-2,273,792		-722,122	581,135	163,903					-739,077	-286,653	-243,669	-36,265	277,831	-128,555	-69,397	-85,590	-305,715			163,661			96,041	143,613			98,689	252,476			90,903	-236,702				38,629							696,082	-113,465	-110,775			391,506	3,988
proceeds from sale of properties, plants and equipment					1,500
purchases of properties, plant, and equipment					-207,538	-72,337	-98,008	-52,713
net cash used by investing activities									178,007	-171,864	-733,086	-614,770	11,899,411			-188,541	-246,831				-22,636	-20,289									-79,583	-94,805	-86,076	-128,221	-71,645	-79,599	-123,060	-98,966	-115,301	-245,702	-360,003	-455,076	-780,248	-108,710	-510,707	-683,568	-336,131	-296,147	-990,979	-486,823	-799,084	-456,876	-978,855	-921,369	-806,322	-807,355	-494,540	-706,989	-937,647	-100,265	-173,568	-422,188	-228,238	-141,925	-285,951	-143,020
payments on dividends payable
net cash provided (used) by financing activities													-225,645	-22,313	-15,710	-4,057					-8,396	1,618,752	447,911	40,098	-118,982	358,811	232,665	-14,988	30,644	-216,791	48,924	-84,462	-138,965	-120,352	-10,975	-62,942		-1,655	-38,110	-2,653				357,815				242,026				-46,252
supplemental disclosure of cash flow information
recognition of operating lease liability and right of use asset
common stock buyback and retirement
conversion of preferred series d to common stock									-1	0	0	16,927
cash flows from operating activities of continuing operations:
net income from continuing operations						-683,097	-55,704	86,101
adjustments to reconcile net income from continuing operations to
net cash provided (used) by operating activities of continuing operations:
allowance for doubtful accounts on accounts receivable						-16,488
other assets						0																								-79,657				0	-35,270	-48,167	-281,683	296	-16,286	1,000	-14,340	92,027	-9,078	-19,227	-49,385	-21,594	11,754	-45,299	151,454	-98,636	-45,163	-21,639	-343,455	-26,355	-6,650	-67,270			13,587	-18,770
net cash provided (used) by operating activities of continuing operations						448,369	85,438	350,225
cash flows from investing activities of continuing operations:
net cash provided (used) by investing activities of continuing operations
cash flows from financing activities of continuing operations:
net cash used by financing activities of continuing operations						-32,068	-17,798	-21,273
net cash flows provided (used) by continuing operations						658,048	-30,368	326,921
cash flows from discontinued operations:
net cash flows provided (used) by discontinued operations						-37,173
noncash recognition of new leases
adjustments to reconcile net income from continuing operations to net cash
provided (used) by operating activities of continuing operations:
loss on disposal of property, plant, and equipment							0	17,494
write down of inventory to net realizable value							-69,642	80,143	1,190,014	427,152			-132,773	273,083
other non-cash items							-411	-15,695												-661
net cash used by investing activities of continuing operations							-98,008	-2,031
net cash used by operating activities								-285,198									46,387																																			-104,389											48,947	-56,404	65,859	-56,130
net cash flows used by discontinued operations								-285,198
\|cash and cash equivalents and restricted cash at beginning of period								11,954,635
adjustments to reconcile net income to net cash
used by operating activities:
loss on disposal of property, plant & equipment
reserve on iva receivable
change in fair value of investments														25,840
change in:
purchase of investments													-2,684,893	289,772
proceeds from sale of investments
purchases of properties, plants and equipment																					-22,636	-20,289
repurchase of common stock
net cash used by financing activities									-213,513	-23,680	-23,347	-810,752
net decrease in cash and cash equivalents and restricted cash									-967,645	-821,935	-1,674,137	-3,699,314
\|cash and cash equivalents and restricted cash at beginning of year
cash and cash equivalents and restricted cash at end of year
issuance of common stock for directors
preferred series d dividends payable declared
adjustments to reconcile net income to net cash provided (used) by operating activities:
provision for losses on receivables
proceeds from sales of investments													15,718,498	10,228
purchase of properties, plants and equipment										-171,864	-733,086	-614,770	-1,134,194	-209,222	-194,458	-188,541		-501,352	-91,829	-23,298				-96,271	-115,088			-312,568	-487,548			-94,805	-86,076			-79,599	-135,870	-98,966	-115,301	-245,702	-360,003	-455,076	-785,448	-108,710	-510,707	-683,568	-336,131	-296,147	-990,979	-486,823	-799,084	-456,876	-977,565	-921,369	-806,322	-564,555	-494,083	-706,980	-937,647	-100,265	-173,192	-422,176	-228,231	-141,925	-285,234	-143,000
principal payments of long-term debt										-23,680	-23,347	-23,022	-22,665	-22,313	-15,710	-4,057		-58,500	-15,408	-12,518				-10,906								-48,681				-53,020				-41,824																-19,520	-14,235	-23,529	-70,812	-16,146	-17,968	-9,453	-16,306	-15,543	-9,363	-19,482
dividends paid										0	0	-787,730
common stock retirement										0
issuance of common stock for directors fees													0
common stock payable for directors fees															46,875	28,125		28,125	28,125	28,125				28,125				31,250				43,750				43,750				37,500
accrued liabilities – directors and related parties												19,746
share retirement												202,980
adjustments to reconcile net income to net cash used by operating activities:
gain on settlement of hillgrove advance																	0	0
gain on forgiveness of cares act debt																		0
loss on disposal of assets
change in value of investments
accrued liabilities – officers and directors
export tax assessment payable																	0	0	0	-1,120,730
purchase of certificate of deposit
change in checks issued and payable																	0	0	0	-86,685	71,931	-145,409	86,428	56,102			67,391	-845			99,533	-17,203			8,743	-21,519												37,179					0	0	0	-113,908				13,371	0	-24,929	-21,467	29,254	-21,721	7,220
payments on advances from related party																	-2	0	-200	-56,216	-18,769	-18,490	-32,227	-13,933	-17,679				-10,000
payments on hillgrove advances payable																	0	0
principal paid on notes payable to bank																		0	0	-100,000								-70,792				-95,448
repurchase of shares to be returned to treasury
equipment purchased with long-term debt
building purchased with note payable
preferred series d dividends declared and payable
prepaid expenses
payable to related parties																																																																	-1,358	4,412
net cash provided (used) by investing activities																								-96,271	-115,088			87,432	-187,548
common stock payable to directors
payable to related party satisfied with exercise of stock purchase warrants
adjustments to reconcile net loss to net cash used by operating activities
cash and cash equivalents at beginning of period																21,420,329																		0	0	10,057		0	0	133,543		0	0	123,683		0	0	20,343		0	0	1,000,811		0	0	5,427		0	0	448,861		0	0	180,613		0
cash and cash equivalents at end of period																21,391,634																		3,026	13,421	11,129		-39,624	-54,722	137,664		129,199	-61,961	136,086		-1,033,302	1,566,625	4,851		-280,852	-27,600	393,294		-1,067,302	2,030,420	1,413,583		196,792	-1,228,898	1,543,176		2,749	-57,565	96,083		-69,478
adjustments to reconcile net loss to net cash
loss on mineral properties
common stock payable for directors' fees																					16,250	28,125
gain of forgiveness of cares act debt
other non cash items																					1	-1
payables to related parties																	0	-16,994	10,900	-164,922	-7,363	0				-6,452				33,659				-437	14,711	-12,477	-28,151	-1,273	11,322	231	-2,546	-3,643	18,512	11,716	-20,251	-7,403	34,545	-14,083	7,015	6,853	-15,499	-342	234,144	2,948	-36,228	-285,316	55,756	3,955	17,366	6,837		1,460	9,564	930
proceeds from issuance of common stock and warrants, net of issuance costs																					0
proceeds from note payable-sba																						0
proceeds from notes payable to bank, net of payments																						-15,135
net increase in cash and cash equivalents																					-770,109	1,311,810				25,997				497,293				3,026								129,199	-61,961	12,403		-1,033,302			-64,499	-280,852	-27,600	-607,517		-1,067,302	2,030,420	1,408,156				1,094,315			-57,565	-84,530
cash and cash equivalents and restricted cash at beginning of year
noncash investing and financing activities:
common stock payable issued to directors																	0				0	0			0	0			0	0			0			168,750				137,500
payable to related party satisfied with exercise of stock
purchase warrant																					0	0
loss on abandonment of mineral properties
net proceeds from (payments to) factor																						-5,644				45,300																							-3,318				-216,910
borrowing on notes payable to bank																								2,488
net increase in cash and cash
equivalents and restricted cash
non-cash investing and financing activities:
payable to related party satisfied with issuance of stock
net cash (used) by operating activities																			213,245	-2,449,854
net increase in cash
and cash equivalents and restricted cash																			-677,723	22,377,228								-13,146
provided (used) by operating activities:
net cash (used) by investing activities																				-23,298
net borrowing from factor																								6,347				-11,084				1,870				-4,388				84,083
common stock issued for warrants
amortization of debt discount																											18,301	18,037			21,120	21,120			23,415	23,413
common stock issued for services																									0	0	0	136,000													0	55,000	0	2,950	0	19,200						2,628
payment received on note receivable for sale of land																										0
advances from related party																													10,000	50,000
proceeds from cares act note payable
proceeds on notes payable to bank
accrued payroll, taxes and interest																						26,196	-32,876	-38,147	60,438	-41,520	-20,581	103,426	23,738	-76,404	16,405	10,015	22,450	-10,500	-19,947	-20,415	-11,767	-63,208	97,990	-30,766	84,154	-31,376	-85,094	118,517	25,185	-80,922	52,117	13,928	24,565	-358	-322	11,511	-3,564	-5,304	-51,879	8,360	63,727	-25,141	4,110	8,729	-20,567	-1,412	18,605	10,020
other accrued liabilities																						23,241	23,581	23,774	-67,168	11,683	11,683	24,099	23,847	124,652	9,563	27,271	15,305	-1,386	25,805	5,886	-61,466	-31,239	22,915	51,213	31,968	13,241	17,817	3,089	2,821	-32,389	14,444	3,190	-24,170	56,520	-15,587	3,762	-2,214	-31,262	30,220	-85,816	-64,512	8,006	-13,203	-31,127	37,764	7,723	-17,895	-35,949	48,195	2,946
other																								-660				-598				-444				-426
payables to related party																								14,923				28,964				8,236
payment received on note receivable
advance from related party																												125,200				75,000
and cash equivalents																								-92,438								-15,606				1,072				4,121
payable to related party satisfied with exercise of stock purchase warrant																								62,500
provided by operating activities:
common stock accrued for directors fees
gain on sale of land
gainon plant acquisition
non-cash miscellaneous income
other current assets																													0	0	0	4,697	19,194	6,857	-25,565	17,918	141,582	101,378	-145,159	114,555	96,703	108,949	-60,761	-339,248	7,133	19,541	9,117	-48,387	170,782	12,880	-5,697	-40,301	-365,058	1	291,843	-41,107	50,243	-64,426	312,611	-336,381
deferred revenue																																116										61,099	46,374	90,810	37,215	-50,623	0	-18,000	18,446	61,692			-31,668	31,668	0	-43,760					-65,000	0	-1,661	-6,361	-75,590	83,612
income taxes payable
proceeds from sale of land
proceeds from plant acquisition																													0
net proceeds (to) from factor
proceeds from sale of common stock and warrants
proceeds from related party loans
properties, plants & equipment acquired with long-term debt																																																								283,940	-5,125	10,800	198,600	30,500		0
note receivable-sale of land
depreciation and amortization expense																																						210,275				222,375	222,375	220,025		189,311	187,357	185,462		135,682	185,416	181,918	123,615	131,990
gain on tax settlement
gain on plant acquisition																													0
amortization of loan discount
common stock payable for director fees
foreign exchange loss																															-62,752	50,000	-16,400	-2,642	10,191	41,451
deferred revenues																													0	0
checks issued and payable
stock issued for cash
advances from related parties
advances from notes payable to bank
payment on advances from related party
proceeds from notes payable to bank																																			8,842	15,985												15,983
principal paid notes payable to bank																																						1	14,239	-44,912
payment received on note receivable - sale of land																												400,000
principal payments of net debt																												-57,467
principal payments on notes payable to bank
net proceeds from factor
hillgrove advance earned credit																																							-52,588	-23,991
redemption of reclamation bonds
cash and cash equivalents at beginning of year
cash and cash equivalents at end of year
income taxes paid in cash
imputed interest capitalized as property, plant and equipment																																								24,353
hillgrove deferred revenue																																										-43,388
foreign income tax payable
properties, plants and equipment acquired with long-term debt																																														0	0	19,040						68,210
income tax payable
gain on sale of equipment
bad debt expense
proceeds from sale of equipment
proceeds from hillgrove advances
received on notes receivable for stock sales
properties, plants & equipment acquired with accrued liability
properties, plants & equipment acquired with other long term assets
forgiveness of note receivable for stock sales
gain on sale of asset																																										0			-30,000	0	-10,900	5,450
write off of uncollectible other asset
gain on liability adjustment																																										0
common stock issued for director fees
proceeds from sale of assets
net proceeds from sale of common stock and exercise of warrants
proceeds from note payable to bank
proceeds from hillgrove
net (decrease) in cash and cash equivalents																																						-39,624
properties, plants and equipment with accrued liability
common stock issued to directors																																						0				0	0	125,000
due to factor																																										118,098	122,198	19,279		153,176	-45,127	40,522			-102,095	281,194
stock payable to directors for services																																										37,500	37,500	37,500
proceeds from issuance of long term debt																																														0	80,000	50,000
increase in notes receivable stock sales
imputed interest included in properties, plants and equipment																																												10,625
principal received on shareholder loan																																												915
properties, plants & equipment acquired with advances
cash received for sale of equipment																																									0
net payments to factor
proceeds from sale of common stock and exercise of
warrants, net of offering costs
principal paid notes to bank
proceeds from long term debt																																																	152,000
payments on related party loans
received on notes receivable for stock
common stock issued for debt payment																																													0	0
common stock issued for note receivable
equipment sold for other asset advances
forgiveness of note receivable-stock
common stock issued to directors for services																																																		0				0							67,600	0	0	49,400
proceed from notes to bank
proceed from hillgrove advances
properties, plants and equipment acquired with other long term assets
equipment sold for note receivable																																														0	0	10,000
common stock issued for notes receivable																																														0
write down of other assets
proceeds from hillgrove advances payable
net proceeds from sale of common stock
proceeds from related party
adjustments to reconcile net loss to net cash used
by operating activities:
gain on sale of fixed asset																																												-5,200
proceeds from bank debt																																												71,906
proceeds from hillgrove ltd																																												294,858
proceeds from sales of equipment, net of depreciation																																												5,200
proceeds from sales of common stock, net of commissions
noncash investing activities:
properties, plants and equipment acquired with advances																																												434,335
deferred income taxes
purchase of certificates of deposit																																																					-1,290	0
proceeds from sale of common stock
and exercise of warrants, net of offering costs
issuance of common stock pursuant to exercise of warrants																																																					0
payments on notes to bank
payments on long-term debt
properties, plants & equipment acquired with accounts payable
imputed interest included in property, plant and equipment
deferred income tax expense																																																		0				0				0
properties, plants and equipment acquired with accounts payable																																																		-60,225	362,810	15,750						0	71,828	17,826		20,501	7,586	18,723
fair value of derivative liability																																																		-36,750
change in operating assets and liabilities
net cash provided by operating activities
proceeds from sales of common stock																																																170,000
net decrease in cash and cash equivalents																																																-15,492										196,792
noncash financing activities:
common stock payable to directors for services
proceeds from sale of common stock and warrants, net of offering costs
payments received on stock subscription agreements																																																									0	22,656	37,528	22,379	77,437	60,000	40,000	26,270	0	1,824
common stock and warrants issued for note payable
proceeds from sale of common stock, net of offering costs																																																						-87,079
common stock issued for prepaid directors fees																																																						68,019
common stock issued pursuant to cashless exercise of warrants
adjustments to reconcile net loss to net cash provided by operating activities:
deferred tax expense																																																								-74,311				21,926
purchase of collateral cd for loan facility
impairment of properties, plant and equipment
and warrants, net of commissions
stock issued for subscription receivable																																																														90,000
write-off of uncollectible stock subscriptions
adjustments to reconcile net income to net cash provided
(used) by operating activities:
depreciation expense																																																								109,045	107,880	105,363	99,537	92,966	92,018	102,590	85,166	76,102	71,640	78,227
collateral cd for loan facility																																																								-242,800
proceeds from sale of common stock, net of commissions																																																								2,462,404	-1	-3,030	379,778	783,470	517,705	88,500	119,499	73,818	407,135	140,110
allowance for doubtful accounts
gain on sale of properties, plant and equipment
extinguishment of payables
restricted cash for reclamation bonds																																																									-457					-12				-20
stock issued for conversion of note payable to related party and
warrants exercised forgiveness of payable to related party
payment of long-term debt with equipment
mexico impairment loss
other receivable
gain on sale of properties, plants and equipment
current deferred tax asset
impairment of properties, plants and equipment
change in restricted cash for reclamation bonds
proceeds from long-term debt
the accompanying notes are an integral part of these consolidated financial statements.
accrued interest payable																																																																		651
warrants exercised for forgiveness of payable and interest to related party
stock issued for conversion of convertible note payable to related party																																																																		0
gain on properties, plants and equipment
gain on expiration of exclusivity agreement
accrued payroll and payroll taxes																																																																	-11,800	2,166
warrants exercised for forgiveness of payable to related party
properties, plants and equipment acquired with a/p																																																																		13,104

United States Antimony Corporation(NYSE MKT:UAMY)

United States Antimony Corporation
(NYSE MKT:UAMY)